Answer
Signifor (pasireotide diaspartate) is contraindicated in patients with hypersensitivity to pasireotide or any excipient listed in section 6.1, or severe hepatic impairment (Child Pugh C).
Sources for this answer
- Signifor 0.3 mg solution for injectionRecordati Rare Diseases UK Ltd · emc · SmPC §4.3 Contraindications · Version 18Document updated
Sources checked